OVID
OVID
NASDAQ · Biotechnology

Ovid Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks
$2.84
-0.05 (-1.73%)
As of Aug 18, 10:14 PM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 15 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +1,345.1% upside
Low Target $30.97
Average Target $41.04
High Target $66.83
Current Price $2.84
Current
$2.84
Target
$41.04
$30.97 $41.04 avg $66.83
Scenario Analysis
Bear Case
$30.97
990.5%
Low target
Base Case
$41.04
+1,345.1%
Avg target
Bull Case
$66.83
+2,253.2%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$3.11
-8.5% from high
52-Week Low
$0.55
+416.4% from low
Target vs 52W High
$41.04
+1,221.7% vs high
Next Earnings Report
Aug 18, 2026
Today
EPS Est: $-0.12
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 -0.5%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -55.1%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +152.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 37 81% $438.34 -17.0%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -90.5%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -54.1%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -47.2%
BIIB
Biogen Inc
 Buy 43 67% $91.45 -57.0%